Renaissance Capital logo

Macrocure Priced, Nasdaq: MCUR

Israeli biotech developing white blood cell injections to treat hard-to-heal wounds.

Industry: Health Care

First Day Return: -27.5%

Israeli biotech developing white blood cell injections to treat hard-to-heal wounds.

Macrocure (MCUR) Performance

Created with Highcharts 10.3.2Chart context menuMCUR vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index